{"name":"Senti Biosciences","slug":"senti-biosciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQY212Q2V0LTd1LUJON1piMURCQUczMmxuYi1HR2wtSnJIWExXbjdMSFZKYmlsb1dlbHcyWk5fWkh4RUFEa25TdmZjNkFzTjRfdjREc282RmRLbzFXS2hmWHJqendwbndodENlMnFyLURfOWRMeGtlM3EtbXE0ZmlhYXItQ0FRbWk3bUtQaQ?oc=5","date":"2026-02-25","type":"pipeline","source":"ascopost.com","summary":"A Paradigm Shift in Treating Adult AML? - ascopost.com","headline":"A Paradigm Shift in Treating Adult AML?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPazZjNWlYcW1BYjJLSTl5Mm5RMGxuTUViX2FnY3hiTjBGMmdJaDVPOWhGZWltTDl6MW5HSXBGc0VTbGJYSEQ3Zm1QWEIyN0hSczdvYzZ2Y2NuZ1pwNXhMT1gwTU9nRTlPT01KMDRiRmtKRmdyd1BuN3NRenUzT3RvMTNNMTZRS1hZS2RYeEV2RmFsUXl5V3pMWk40QXpTWkRQZjl6WVdGZ3IwUXRiRUdDWHNFSkdHU1JVOUdzOEpB?oc=5","date":"2026-01-09","type":"pipeline","source":"Stock Titan","summary":"Inside the next wave of cell and gene therapies in San Francisco this January - Stock Titan","headline":"Inside the next wave of cell and gene therapies in San Francisco this January","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPaVo5SVFLdWcyWloxSk1JdWVOSERrWTR1eElnTDZBNTloTnRla0tobl9pV3phWHItQ1IyWC1kdHprdkRteUFoUmkwNDVTQU1MeHZ5TXUtTk1wUEEteFh3NkxqMGh3UE5UaHU0ZVpQZUZNOHgyU3dRczh2WFZLYjVEaEV4RHl6U013V3B1MjdsbWgwaWNrNU9sTklNRS1yUF82ai1PRGZtOWtfWW5Mck9ZMU1YVFB6dw?oc=5","date":"2025-12-11","type":"regulatory","source":"geneonline.com","summary":"Senti Bio Wins FDA RMAT Designation for SENTI-202 on 50% Response Rate in Leukemia Trial - geneonline.com","headline":"Senti Bio Wins FDA RMAT Designation for SENTI-202 on 50% Response Rate in Leukemia Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOUGt6eTY0UkFGNk1ON01sVVUza1RxTDl4OGc0MXVtNUJfdXIwY0lqN1o2eDVSeFlLUnIxbTQtdW1SdnNqVHAtSkQtV3ZpWFloelFMWGJUendUQnFGVXhPNnV0U3p0eW9YUHFNXzhpcWVkcW01UWFRdmw3ZjkwVGZsR1JPYlNHMUN3TWNVSm9oTnFXR2VWcExtUm9Ra2tjSmsxU29NSGlwVEF0LW5MY1Vsaw?oc=5","date":"2025-07-24","type":"pipeline","source":"citybiz","summary":"T. Rowe Price, Catalio Capital Join $100 Million Series D for Avalyn Pharma - citybiz","headline":"T. Rowe Price, Catalio Capital Join $100 Million Series D for Avalyn Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNaG9TZTFGWlVrX2JXOFJqOTRkcF9wYzRKSzhfamtCOVAxQW5UUVpUUm9fZVF6WndBcWZLWkRydERjeWpmZ0IyZlB0T1pyMUc3YkplWjZQU3M3aWJoT0U0OHVyellyWjBYZWZJaWhpWDRsdUF2UHFzOUlyRE5SSVBFVjdLeUZ5cDZQd1VxRnJfQjk1OXZQVlVQd3FNbkhXelAteUxoODJpWnR1d2NVb3pUejJBUzN3clhicGxpU2pQQ2k?oc=5","date":"2025-04-27","type":"pipeline","source":"Pharmacy Times","summary":"AACR 2025: Off-the-Shelf CAR NK Therapy SENTI-202 Shows Potential for Complete Remission in R/R AML - Pharmacy Times","headline":"AACR 2025: Off-the-Shelf CAR NK Therapy SENTI-202 Shows Potential for Complete Remission in R/R AML","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQdUFPMTVLNjZ0TVBkY1BGOHJoT2pJcXZpbmlUMEJ0WUZWVGt1R0x1dHk1UmNRLVFPdUk1N1lMWFBQM0h4dERBSGpOa2tEWUVDRHBwMHM0dG11eURPODlSdFB1cTJIUVdiTXUyMHlQM2hlVEFIY1RGTjVGSlN1cGp6MFRrT2VIdWhZRU9qbno2VnF5WVA4eTNrWW9qVQ?oc=5","date":"2025-03-27","type":"trial","source":"Oncology Pipeline","summary":"AACR 2025 preview – distressed biotechs seek redemption | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"AACR 2025 preview – distressed biotechs seek redemption | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNRDJoSlFBV0RZWWhjeXY4Sk9HeHU5QUw0OHEzb3MzMGlEQTBEQTFlclV2M3BUT3pBQzRSZWVHNlpkejN2R3lRUVJUWndyb2ZmWmZsS0haWE9VMXFxYlB4UVU2OWlVWmp5RjNONGw1dWpiRlJtbkNFMlUxbUlRT0ZBelhGTnFjN3hzZkNrbG5udDRZZ19ZNGs2YWJyYWZHdw?oc=5","date":"2024-12-03","type":"trial","source":"The Pharma Letter","summary":"Senti Biosciences reports early success in AML trial - The Pharma Letter","headline":"Senti Biosciences reports early success in AML trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNa1U3NmNGVHZObHgyZFB3emQ1OWlGSDJjS2FSeXJubnRVOUhEcXp5bzhtWGhoMHhpSUJLaUN6QXBlbTJpaGMyS1pZQ3B2eV8wWkotQm1WdDZlWmJLWmlXNnZHYVNtZEpUV0IxSDZsTHR6NklyRFFHZ3c0bHFjellFSVRYWXBkb0NFekJIQ3FqYnhoN1NnTl9aZ2ZXSnlLOWljcUFub1JiVjFyVkFybVNVanpxVENDX3FheUlseWUyY2k?oc=5","date":"2024-01-08","type":"trial","source":"Pharmaceutical Technology","summary":"Senti Bio cuts 37% of workforce to free funds for cell therapy cancer trials - Pharmaceutical Technology","headline":"Senti Bio cuts 37% of workforce to free funds for cell therapy cancer trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOeTB2Ym0zWDZOQk11UkhjVmYzLWNrdVJOYnUtUF94aWhxcWFSZl8tbENweDB1U3lpbF9TM0FCbDZNTmVnVjI5bzczVTRYekZpNHV6RnM5QzhNcl82dmdzMnByUmdRX0c3MnI1MkpoZXN0QWtCY0tHamllLVVLd01KUXZGdE9NV28yS0NWeVpqUnJOOEpqMXlielo1ckdPUQ?oc=5","date":"2023-08-14","type":"pipeline","source":"Contract Pharma","summary":"GeneFab to Sublease Senti Biosciences cGMP Facility - Contract Pharma","headline":"GeneFab to Sublease Senti Biosciences cGMP Facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxORm1VbjliOG1VSlpZZGJCOUNjR2pIY1ZHSTFrc0dGeHBGS3BmbWsyZjMzbnJZTUJzdHhkSFhEV2NnQUNTdXlud1MybTA5YjNJSDZrV3k1cTV3T0t3SjhnQVlRNE1IUFJQZV9VRHdpU3dmX0tZQWtqdFVmeWZfYkhqR1FkWmI0LWJTRnE0aHpPcWx4U3dLNlAzb2U1OWZfVkxzQllwZHVqeWdqbzM4VHc?oc=5","date":"2023-08-14","type":"deal","source":"Fierce Pharma","summary":"GeneFab debuts as manufacturer, acquires Senti Bio's production tech for $38M - Fierce Pharma","headline":"GeneFab debuts as manufacturer, acquires Senti Bio's production tech for $38M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOZDlSZEJyQXNLcEMwYzk4UVo3NDd0WHZ4TXgxYWNDN3pkMzQ3YW5MeDIxR3V3Tml5SVFfVVRyNUdlclA5WWxyVW11b2QxMkpPeVQ5MzE3aUZSY2xVcVlMUGtYMkg0cVlLSVR5dVJTS1o2WWx4RENGbXlqdUVNMjhJTE9NbjVub0tZMTJOd01OcS1HS3FsWHFkdHNRel96UXZtaXhzbHBsa0VRaFR1SVE?oc=5","date":"2021-04-14","type":"pipeline","source":"Fierce Biotech","summary":"Senti Biosciences in $645M Spark pact to drive gene circuits into the fast lane - Fierce Biotech","headline":"Senti Biosciences in $645M Spark pact to drive gene circuits into the fast lane","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxONHRKT2VYQXNaNzFzNlVSeDZPZ19PZVlWUl9ZeE5GUXI3dkRQNlNBYmVEUG1VQ3VaaC1sR1BSQllOZEFBaGQ3T1ZVc0gwd3pFN0V3RlVvTWtxRVEtN2xfUXZaNG96SWgtTzdGMGtvZW9kZ0owQzBHa3UzSTR2QmZ0eQ?oc=5","date":"2021-01-06","type":"pipeline","source":"BioPharma Dive","summary":"Leading $105M biotech funding, Bayer deepens cell therapy investment - BioPharma Dive","headline":"Leading $105M biotech funding, Bayer deepens cell therapy investment","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}